3d
Inquirer on MSNUS approves 1st fast-acting insulin biosimilar for diabetesThe US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls ...
6don MSN
Why it matters: More than 3.5 million Californians have diabetes, and insulin is a life-saving part of their disease ...
4d
The Punch on MSNNAFDAC alerts Nigerians on circulation of substandard insulin syringesThe National Agency for Food and Drug Administration and Control has raised the alarm over the illegal circulation and ...
Biocon Biologics has partnered with Civica to improve access to and affordability of insulin aspart in the U.S. Biocon will ...
Metformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for ...
FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...
Biocon Biologics partners with Civica to enhance access to Insulin Aspart in the US, no tech transfer involved.
People on Ozempic and other GLP-1 agonist drugs commonly report they no longer have constant, incessant thoughts about food.
Tandem is following competitor Insulet’s lead with the second automated insulin delivery system indicated for Type 2 diabetes ...
During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results